Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

As of 12:56:13 pm GMT-4. Market open.

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $38.54, denoting a -1.76% change from the preceding trading day. Gene therapy developer CRISPR Therapeutics AG ...

It has been 20 years since the term “genome editing” first entered the scientific lexicon, a field that was revolutionized by the development of CRISPR gene editing in 2012. But the remarkable ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease. The genetic bases of the seven pairs of contrasting ...

Under the terms of the arrangement, EditCo will incorporate Promega’s bioluminescent and protein-labeling technologies into its CRISPR-engineered cell lines. According to the partners ...

Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research. US, NY, UNITED STATES, April 22, 2025 /EINPresswire.com ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.